■ Update on the etiopathogenesis of psoriasis (Review)

D E Branisteanu, C Cojocaru, R Diaconu et al

Exp Ther Med 2022, vol 23 (3): 201

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8794554/

 

■ Cardiovascular comorbidities in psoriasis (Reviews)

D E Banisteanu, A C Nicolescu, D C C Brtanisteanu et al

Exp Ther Med 2022, vol 23 (3):152

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8753969/

 

■ Treatment options and goals for patients with generalized pustular psoriasis

James Krueger, Lluís Puig, Diamant Thaçi

Am J Clin Dermatol. 2022; 23(Suppl 1): 51–64

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8801408/

 

■ Metabolic comorbidities of psoriasis (Review)

D E Branisteanu, R A Pirvulescu, A E Spinu et al

Exp Ther Med 2022, vol 23 (2)

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8764894/

 

■ The role of chemokines in psoriasis – an overview

N Zdanowaska, M Kasprowicz-Furmanczyk, V Placek, A Owczarczyk-Saczonek

Medicina (Kaunas) 2022, vol 57 (8): 75

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8400543/

 

■ Chronic inflammation as the underlying mechanism of the development of lung diseases in psoriasis: a systemic review

Mateusz Mleczko, Agnieszka Gerkowicz, Dorota Krasowska

Int J Mol Sci. 2022 Feb; 23(3): 1767

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8836589/

 

■ Generalized pustular psoriais (von Zumbusch)

Ricardo Romiti, André Luís da Silva Hirayama, Marcelo Arnone, Renata Ferreira Magalhães

An Bras Dermatol. 2022 Jan-Feb; 97(1): 63–74

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8799844/

 

■ Generalized pustular psoriasis in Brazil: A public claims database study

Gleison Vieira Duarte, André Vicente Esteves de Carvalho, Ricardo Romiti, et al

JAAD Int. 2022 Mar; 6: 61–67

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8760386/

 

■ Risk of developing melanoma with systemic agentes used to treat psoriasis: a review of the literature

Amy Semaka, Thomas G. Salopek

J Cutan Med Surg. 2022 Jan; 26(1): 87–92

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8750137/

 

■ Non-alcoholic fatty liver disease (NAFLD) in patients with psoriasis: a review of the hepatic effects of systemic therapies

D M W Balak, S Piaserico, I Kasujee

Psoriasis: Target and Therapy 2022, vol 11: 151-168

https://www.dovepress.com/non-alcoholic-fatty-liver-disease-nafld-in-patients-with-psoriasis-a-r-peer-reviewed-fulltext-article-PTT

 

■ The use of apremilast in psoriasis: na Indian perspective on real-world scenarios

M Rajagopalan, S Dogra, A Saraswat et al

Psoriasis: Target and Therapy 2022, vol 11: 109-122

https://www.dovepress.com/the-use-of-apremilast-in-psoriasis-an-indian-perspective-on-real-world-peer-reviewed-fulltext-article-PTT

 

■ Acesso gratuito

■ Um dos Blog de Medicina mais acessado em todo o mundo. Mais de 500 temas médicos já disponíveis online

■ Use o mecanismo de busca – PESQUISAR na home page.

■ Acesse ARQUIVO e encontre os temas incluídos no Blog a cada mês, desde maio 2017

■ Blog Internet Médica – www.internetmedica.com.br

■ Médico Responsável: Dr Paulo Fernando Leite

CRMMG: 7026

Belo Horizonte/MG/Brasil

Email: pfleite1873@gmail.com

Fevereiro 2022